Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Takehiro Tozuka

10PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Oct 11, 2025
ACTN4 Gene Amplification and Actinin-4 Protein Expression for Osimertinib Efficacy in EGFR-Mutant NSCLC.

Takehiro Tozuka, Rintaro Noro, Yutaka Naito

|Jun 26, 2024
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.

Yasuhiro Kato, Masaru Matsumoto, Natsuki Takano

|Sep 11, 2023
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancer.

Takehiro Tozuka, Rintaro Noro, Akihiko Miyanaga

|Jun 29, 2023
Remarkable Clinical Response of <i>ALK</i>-Rearranged/<i>TP53</i>-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report.

Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma

|Jun 08, 2023
Platinum-combination chemotherapy with or without immune-checkpoint inhibitor in patients with postoperative recurrent non-small cell lung cancer previously treated with adjuvant platinum-doublet chemotherapy: A multicenter retrospective study.

Kakeru Hisakane, Takehiro Tozuka, Satoshi Takahashi

|Jan 31, 2023
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report.

Kazuhito Misawa, Shinji Nakamichi, Hiroki Iida

Pageof 2

Frequent Collaborators

5 joint publications

Akihiko Miyanaga

2 joint publications

Rintaro Noro

2 joint publications

Yasuhiro Terasaki

2 joint publications

Susumu Takeuchi

1 joint publications

Shinji Nakamichi

1 joint publications

Natsuki Takano

1 joint publications

Shinya Uematsu

1 joint publications

Hisashi Tanaka

1 joint publications

Masaki Kanazu

1 joint publications

Makoto Nishio

Frequent Collaborators

5 joint publications

Akihiko Miyanaga

2 joint publications

Rintaro Noro

2 joint publications

Yasuhiro Terasaki

2 joint publications

Susumu Takeuchi

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

4.5K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on : May 30, 2012

18.7K
See more related videos

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

4.5K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on : May 30, 2012

18.7K
See more related videos